Genetic Technologies Ltd (ASX:GTG; Nasdaq:GENE) is the most active stock intra-day with over 113 million shares changing hands, although its value has eased 10.5% to $0.017.
The company has regained compliance with Nasdaq Marketplace following a deficiency notice in mid-2017.
Genetic Technologies is a molecular diagnostics company that offers cancer predictive testing and assessment tools to help physicians proactively manage patient health.
The company’s lead product, BREVAGenplus®, is a clinically validated risk assessment test for non-hereditary breast cancer and is first in its class.
Adding interest and following a strategic review, the company remains in active discussions with multiple parties regarding a potential transaction.
Further details will be closely monitored by investors.
Company Name · Code · Last · Change · Volume
Genetic Technologies Ltd · GTG · $0.017 · -10.53% · 113,744,014
Pancontinental Oil & Gas NL · PCL · $0.005 · 0% · 95,747,144
Queensland Bauxite Ltd · QBL · $0.069 · -8% · 71,822,947
Bard1 Life Sciences Ltd · BD1 · $0.016 · 33.33% · 64,333,658
Atlas Iron Ltd · AGO · $0.032 · -3.03% · 64,299,962
Ardiden Ltd · ADV · $0.023 · 15% · 61,450,080
Serpentine Technologies Ltd · S3R · $0.017 · 21.43% · 49,188,225
Fatfish Internet Group Ltd · FFG · $0.100 · 21.95% · 36,935,922
Kairos Minerals Ltd · KAI · $0.055 · 14.58% · 32,602,587
Lepidico Ltd · LPD · $0.067 · 6.35% · 27,529,056